1129540-72-2 Usage
General Description
1-(4-Amino-phenyl)-3-bromo-1,2,4-triazole is a chemical compound with the molecular formula C7H6BrN3. It is a triazole derivative that contains both an amino group and a bromine atom. 1-(4-AMINO-PHENYL)-3-BROMO-1,2,4-TRIAZOLE is commonly used in organic synthesis and medicinal chemistry as a building block for the production of various pharmaceuticals and agrochemicals. It has also been studied for its potential antifungal and antimicrobial properties. Additionally, it can be utilized as a precursor for the synthesis of diverse heterocycles and dyes. As with any chemical compound, proper handling and storage of 1-(4-amino-phenyl)-3-bromo-1,2,4-triazole is necessary to prevent any potential hazards and ensure its safe use.
Check Digit Verification of cas no
The CAS Registry Mumber 1129540-72-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,9,5,4 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1129540-72:
(9*1)+(8*1)+(7*2)+(6*9)+(5*5)+(4*4)+(3*0)+(2*7)+(1*2)=142
142 % 10 = 2
So 1129540-72-2 is a valid CAS Registry Number.
1129540-72-2Relevant articles and documents
MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
-
Page/Page column 324-325, (2021/02/12)
This disclosure relates to compounds having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such compounds and intermediates used in such processes, compositions containing such compounds, and processes of using such compounds against such pests. These compounds/molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses compounds having the following formula (Formula One and/or Formula One-A).
SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 77, (2009/04/25)
The present invention provides novel substituted pyrimidinyl-amines that are useful as inhibitors of protein kinases, especially c-Jun N-terminal kinases (JNK) and pharmaceutical compositions thereof and methods of using the same for treating conditions responsive to the inhibition of the JNK pathway.
